K Otani, S Kaneko, Y Fukushima, K Chiba, T Ishizaki. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AdultAgedFemaleHaloperidol/adverse effectsHaloperidol/pharmacokineticsHumansInactivation, Metabolic/geneticsMaleMiddle AgedNeuroleptic Malignant Syndrome/bloodNeuroleptic Malignant Syndrome/geneticsPerphenazine/adverse effectsPerphenazine/pharmacokineticsPhenotypeRisk Factors
Substances： See more » PerphenazineHaloperidol
Year: 1991 PMID： 1751888 DOI： 10.1192/bjp.159.4.595
Source DB: PubMed Journal: Br J Psychiatry ISSN： 0007-1250 Impact factor: 9.319